Mas texto en la ventana.
BioSpain 2014 increases its internationalisation by 43% compared to the previous edition
Ana Mato, Minister for Health, Social Services and Equality, Regional Ministers for Health, Economy, Environment and Agriculture from all around Spain and Alberto Nuñez Feijoó, the President of Galicia have inagurated Biospain 2014
Santiago de Compostela, 24th September 2014. Biospain 2014, the 7th international Biotechnology Conference (www.biospain2014.org), the main biotechnology event held in Spain and one of the biggest in the world opens its doors today, until the 26th of September, at the Palacio de Congresos y Exposiciones de Galicia, in Santiago de Compostela (A Corunna). The biennial event, which is organised by the Spanish Bioindustry Association (ASEBIO) – and on this edition also by the Autonomous Government of Galicia, the University of Santiago de Compostela, the University of Vigo and Santiago City Council- has again bolstered its international character: from the over 800 private and public institutions institutions attending the fair (an increase of up to 10%), 300 are non-Spanish and represent a total of 36 countries, almost 40% of this year's total, compared to 28% at the last edition, an increase in internationalisation of 43% compared to 2012.
This 7th edition of Biospain, which coincides with the Year of Biotechnology in Spain and the 15th anniversary of ASEBIO, will count with the presence of 200 exhibitors and 50 investors, including venture capital funds, big pharma investment funds, business angels and others, all of whom will participate in the Investment Forum, where the business plans of 40 companies from a variety of countries will be studied. The partnering event expects to surpass 3000 business meetings and 2000 attendants, potentially making Biospain 2014 the fourth biggest industry event globally in terms of the number of business development meetings.
“Biospain is the best expression of the potential of a sector which has never been as close to success but that at the same time needs support from the Administration and financial sector more than ever in order to fully consolidate itself,” underscored Jorge Barrero, Director of Biospain 2014.
Ana Mato, Minister for Health, Social Services and Equality, accompanied by Alberto Nuñez Feijoó, President of Galicia, and around 20 Regional Ministers for Health, Economy and Environment, as well as Simon Manley, the UK Ambassador in Spain and other officials have today visited the commercial fair at Biospain 2014. This evening the Minister for Health and her Regional counterparts will participate in an informal inter-regional meeting which will consider issues including health innovation policies, one of the topics on the event programme.
In 2012, Biospain confirmed itself to be one of the main international biotechnology business events, becoming the fifth biggest in terms of the number of partnering meetings and participating companies and the biggest country-based event in Europe.
High level scientific conferences
BioSpain 2014 will count with top level speakers, amongst some of the most notable are professionals such as Luiz Sampaio, Assistant Medical Director at Regenerative Medicine Research, Texas Heart Institute (USA), who has been involved in important discoveries in the field of Stem-Cell-Based Cardiac Tissue Engineering; Gerardo Jiménez, Adjunct Professor of Epidemiology, Department of Epidemiology - Harvard School of Public Health (USA) & Professor of Genomic Medicine, as well as Joseph Fernández and Jay Short, protagonists of some of the biggest success stories in US biotechnology with Invitrogen and Stratagene.
“Other important new features of this fair will be the Biolatam Showcase, an exclusive space for Latin American biotechnology in which countries such as Mexico, Colombia, Costa Rica, Brazil, Chile and Uruguay will be present; the Xacobio, which took place between the 21st and the 23rd of September and during which 25 participants from 17 countries have shared an unforgettable experience while following the Camino de Santiago; and the II edition of the Training and Employment Forum, which will be attended free of charge by 300 job seekers and students from the sector, one of the few industries which has continued creating jobs during the crisis,” stated Jorge Barrero.
BioSpain 2014 has also, for the first time, integrated the 'Open Innovation' model, which is currently being adopted throughout all business sectors. Consequently, the fair has ceded control over some of its content to high profile partners: “We have opened the conference to 10 scientific societies which have helped to enrich our programme and we will also host the 'Stakeholder Forum,' through which, also for the first time, we will open our doors to a 'non-professional' public in order to discuss experiences and perspectives, in a dialogue which will include patients, consumers, farmers and environmentalists,” he explains.
The 'Stakeholder Forum' will offer content created by and for patients, consumers and job seekers, who will have their own space within the event. Some of the content will be streamed online, another new feature which will allow for debate on the social media during and after the sessions.
Meeting point for the innovative health community
This year's fair has also been conceived as a meeting point for the innovative health community. That is - the event is not only aimed at the health biotechnology, pharmaceutical or medical devices industries but also at biomedical research centres and, most importantly, at hospitals which are committed to technology transfer and research. ASEBIO categorises this concept within the frame of Entrepreneurial Hospitals.
Finally, another notable new feature is the diversification towards other biotechnology user markets such as the chemicals, agrifood and cosmetics industries, as well as other business niches like marine and forestry biotechnology as well as what is often called the bioeconomy. This is an area which in Europe is being seen as a sustainable alternative to the fossil fuel based economy, and one from which a wide range of products and materials (fuels, plastics, lubricants etc.) can be obtained using plant waste or industrial crops as raw materials.
That s why green, or agrifood, biotechnology will have an important place at the fair, with a total of nine sessions which will cover the emergence of new technologies, the development of new products, the revalorisation of agrifood resources, as well as plant improvement and new varieties resulting from today's cutting-edge biotechnology.
The official sponsors for BioSpain 2014 are Bioibérica, Merck, MSD, Zeltia Group, Roche Institute and CLAMBER (Castilla La Mancha Bioeconomy Region).
For further information:
Head of Communications for BioSpain 2014 and ASEBIO
Landline: + 34 912109374/10
Mobile: + 34 663 117 293
BioSpain 2014 Press Office: BERBÉS ASOCIADOS
María González / Jorge Sánchez / Irene Fernández
Landline/mobile: 91 563 23 00 / 677 456 806 / 678 544 149 / 661 67 82 83
Twitter: @BioSpain2014 (https://twitter.com/BioSpain2014)
Linkedin Group: ‘BioSpain 2014’
Inversores de 11 países analizan 30 proyectos de biotecnología españolaRead more
El top ten de fondos de inversión asistentes a Biospain 2016 gestionan activos valorados en más de 5.000 millones de eurosRead more
The ten biggest funds at Biospain 2016 manage assets of over 5 billion eurosRead more
Los pacientes piden en Biospain 2016 una participación activa en las políticas de salud y en el sistema sanitarioRead more
El descubrimiento del ‘GPS humano’ abre una nueva era en la ingeniería genéticaRead more
La biotecnología agrícola, clave para afrontar el problema de la superpoblación y el cambio climáticoRead more
Biospain 2016 ya cuenta con una APP gratuita para seguir el eventoRead more
US expects to increase its presence in Biospain 2016Read more
Bilbao will host BioSpain 2016Read more
BioSpain 2016 will be the hub of Biotechnology in AutummRead more
Bilbao acogerá BioSpain 2016Read more
EE.UU. prevé incrementar su presencia en Biospain 2016Read more
BioSpain 2016 selecciona a cuatro sociedades científicasRead more
El 82% de los asistentes a Biospain identificaron oportunidades reales de negocioRead more
82% of participants at Biospain identified real business opportunitiesRead more
La inmunoterapia se postula como uno de los pilares terapéuticos del cáncerRead more
La bioeconomía se consolida como una herramienta clave para afrontar los retos futuros del planetaRead more
Participantes en Biospain de 16 países llegarán a la feria por el camino #XacobioRead more
BioSpain 2014 amplía su Foro de Inversión con más perfiles de inversores y más empresas participantesRead more
BioSpain 2014 expands its Investment Forum through wider range of investor profiles and more participating companiesRead more
BioSpain 2014 refuerza su presencia internacional e incorpora el modelo de “Innovación en abierto”Read more
BioSpain 2014 strengthens its international presence and includes ‘Open Innovation’ modelRead more